Journal of Applied Physiology Add DOIs to your references at manuscript stage!
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 102: 1677-1686, 2007. First published November 9, 2006; doi:10.1152/japplphysiol.01145.2006
8750-7587/07 $8.00
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow All Versions of this Article:
102/4/1677    most recent
01145.2006v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tidball, J. G.
Right arrow Articles by Wehling-Henricks, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tidball, J. G.
Right arrow Articles by Wehling-Henricks, M.

INVITED REVIEW

HIGHLIGHTED TOPIC
Free Radical Biology in Skeletal Muscle

The role of free radicals in the pathophysiology of muscular dystrophy

James G. Tidball1,2 and Michelle Wehling-Henricks1

Departments of 1Physiological Science and 2Pathology and Laboratory Medicine, University of California, Los Angeles, California

Null mutation of any one of several members of the dystrophin protein complex can cause progressive, and possibly fatal, muscle wasting. Although these muscular dystrophies arise from mutation of a single gene that is expressed primarily in muscle, the resulting pathology is complex and multisystemic, which shows a broader disruption of homeostasis than would be predicted by deletion of a single-gene product. Before the identification of the deficient proteins that underlie muscular dystrophies, such as Duchenne muscular dystrophy (DMD), oxidative stress was proposed as a major cause of the disease. Now, current knowledge supports the likelihood that interactions between the primary genetic defect and disruptions in the normal production of free radicals contribute to the pathophysiology of muscular dystrophies. In this review, we focus on the pathophysiology that results from dystrophin deficiency in humans with DMD and the mdx mouse model of DMD. Current evidence indicates three general routes through which free radical production can be disrupted in dystrophin deficiency to contribute to the ensuing pathology. First, constitutive differences in free radical production can disrupt signaling processes in muscle and other tissues and thereby exacerbate pathology. Second, tissue responses to the presence of pathology can cause a shift in free radical production that can promote cellular injury and dysfunction. Finally, behavioral differences in the affected individual can cause further changes in the production and stoichiometry of free radicals and thereby contribute to disease. Unfortunately, the complexity of the free radical-mediated processes that are perturbed in complex pathologies such as DMD will make it difficult to develop therapeutic approaches founded on systemic administration of antioxidants. More mechanistic knowledge of the specific disruptions of free radicals that underlie major features of muscular dystrophy is needed to develop more targeted and successful therapeutic approaches.

nitric oxide; muscle disease



Address for reprint requests and other correspondence: J. G. Tidball, Dept. of Physiological Science, 5833 Life Science Bldg., Univ. of California, Los Angeles, CA 90095 (e-mail: jtidball{at}physci.ucla.edu)




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. A. Grimsrud, H. Xie, T. J. Griffin, and D. A. Bernlohr
Oxidative Stress and Covalent Modification of Protein with Bioactive Aldehydes
J. Biol. Chem., August 8, 2008; 283(32): 21837 - 21841.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
K. Hnia, J. Gayraud, G. Hugon, M. Ramonatxo, S. De La Porte, S. Matecki, and D. Mornet
L-Arginine Decreases Inflammation and Modulates the Nuclear Factor-{kappa}B/Matrix Metalloproteinase Cascade in Mdx Muscle Fibers
Am. J. Pathol., June 1, 2008; 172(6): 1509 - 1519.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. P. Whitehead, C. Pham, O. L. Gervasio, and D. G. Allen
N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice
J. Physiol., April 1, 2008; 586(7): 2003 - 2014.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
Y. Lecarpentier
Physiological role of free radicals in skeletal muscles
J Appl Physiol, December 1, 2007; 103(6): 1917 - 1918.
[Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. B. Reid
Editorial
J Appl Physiol, April 1, 2007; 102(4): 1299 - 1300.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.